Global Pet Cancer Therapeutics Market Expected to Hit $0.72 Billion by 2030, Growing at 11% CAGR

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.


What Are the Projections for Pet Cancer Therapeutics Market Size and CAGR During 2026-2030?
The pet cancer therapeutics market size has grown rapidly in recent years. It will grow from $0.43 billion in 2025 to $0.48 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising incidence of cancer in companion animals, development of conventional chemotherapy protocols, increasing veterinary hospital infrastructure, advancements in diagnostic imaging for pets, growth of companion animal population.

The pet cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $0.72 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to advancements in immunotherapy and targeted therapy, integration of artificial intelligence in diagnosis and treatment, expansion of online and retail pharmacy channels, increasing awareness of early cancer detection, rising investment in veterinary oncology research. Major trends in the forecast period include rising adoption of targeted therapies for pet cancer, increasing use of immunotherapy in companion animals, expansion of multi-modal cancer treatment protocols, growing focus on early cancer detection in pets, integration of palliative care in pet oncology.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9984&type=smp

What Are the Key Market Drivers and Opportunities in the Pet Cancer Therapeutics Market?
The increasing prevalence of pet cancer is expected to propel the growth of the pet cancer therapeutics market going forward. Pet cancer refers to the development of abnormal and uncontrolled cell growth in the body of a domesticated animal, such as a dog or cat, leading to the formation of a tumor. The increased prevalence of pet cancer is mostly driven by exposure to environmental toxins and pollutants, whereas genetic and lifestyle factors, as a result demand for more advanced and effective cancer therapeutics for pets is expected to increase. Pet cancer therapeutics help pet cancer by targeting and destroying cancer cells or slowing tumor growth, which improves survival outcomes and reduces pain and discomfort in affected animals. For instance, in 2025, according to the American Veterinary Medical Association (AVMA), a US-based Veterinary Health Authority, approximately 1 in 4 dogs will develop cancer in their lifetime, and this risk grows to 1 in 2 for dogs aged over 10. Therefore, an increasing prevalence of pet cancer will fuel the pet cancer therapeutics market growth.

Which Are the Leading Segments in the Pet Cancer Therapeutics Market?
The pet cancer therapeutics market covered in this report is segmented –

1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer
2) By Species: Dogs, Cats, Other Species
3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, Tomotherapy, Other Therapies
4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users

Subsegments:
1) By Melanoma: Surgical Interventions, Chemotherapy, Immunotherapy, Targeted Therapy
2) By Mast Cell Cancer: Surgery, Chemotherapy, Tyrosine Kinase Inhibitors, Radiation Therapy
3) By Lymphoma: Chemotherapy Protocols, Steroid Therapy, Radiation Therapy, Immunotherapy
4) By Mammary And Squamous Cell Cancer: Surgical Treatment, Chemotherapy, Radiation Therapy, Palliative Care Options

What Are the Significant Trends in the Pet Cancer Therapeutics Market Across Regions?
Major companies operating in the pet cancer therapeutics market are developing technologies such as epigenetic technology to enhance treatment efficacy and precision in targeting cancer cells, ultimately improving outcomes for pets affected by cancer. Epigenetic technology refers to methods that modify gene expression without changing the underlying DNA sequence, often influencing cellular behavior and potential therapeutic outcomes. For instance, in April 2024, VolitionRx Limited, a US-based multi-national epigenetics company, launched the Nu.Q Vet Cancer Test. The Nu.Q Vet Cancer Test operates on the Element i+ Analyzer, allowing for quick results, typically within about 6 minutes. It utilizes an enzyme-linked immunosorbent assay to detect circulating nucleosomes in the blood, which can indicate the presence of cancer.

Who Are the Leading Companies in the Pet Cancer Therapeutics Industry by Revenue?
Major companies operating in the pet cancer therapeutics market are AB Science, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Torigen Pharmaceuticals Inc., Dechra Pharmaceuticals plc, AdvaVet Inc., Oasmia Pharmaceuticals AB, Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc., Boehringer Ingelheim GmbH, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Norbrook Laboratories Ltd., Zenoaq Co. Ltd., Morphogenesis Inc.

Get the full pet cancer therapeutics market report here:
https://www.thebusinessresearchcompany.com/report/pet-cancer-therapeutics-global-market-report

Which Regions Are Driving the Most Demand in the Pet Cancer Therapeutics Market?
North America was the largest region in the pet cancer therapeutics market in 2025. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. How has the ammonia grown historically, and what trends indicate future expansion? The ammonia market size has grown strongly in recent years. It will grow from $79.13 billion in 2024 to $85.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to agricultural demand, expanding population, energy and power generation, chemical manufacturing:. The ammonia market size is expected to see strong growth in the next few years. It will grow to $124.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to hydrogen economy development, renewable energy, carbon capture and storage (ccs), clean energy transition. Major trends in the forecast period includ...
Read more

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the poultry disinfectant industry by 2029? The poultry disinfectant market size has grown strongly in recent years. It will grow from $4.67 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to demand for biosecurity and disease prevention, growth in poultry farming and agriculture, expansion of food safety regulations, use in hatcheries and broiler farms, regulatory standards for poultry hygiene. The poultry disinfectant market size is expected to see rapid growth in the next few years. It will grow to $7.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to sustainable and eco-frie...
Read more

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Ammonium Sulfate industry. What is the projected value of the ammonium sulfate market by 2029? The ammonium sulfate market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to economic growth, agriculture demand, government subsidies, population growth, rise in chemical industry. The ammonium sulfate market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing crop yields, environmental regulations, food security concerns, rising pharmaceuticals sector, rise in disposable income. Major ...
Read more